#Gilead Sciences

These 20 groups received grants from Gilead’s Racial Equity Community Impact Fund.

The antiviral drug is the first treatment for the new coronavirus to be approved in United States.

4% of total U.S. AIDS philanthropy directly addresses African Americans. Plus: Meet the top five funders helping BIPOC communities.

A low-cost generic version of Truvada as PrEP will hit the market September 30.

The results of GLAAD’s first State of HIV Stigma Study coincide with news of a $9 million Gilead grant to fight HIV in the South.

Plus: The Elizabeth Taylor AIDS Foundation and Gilead Sciences join the collective for a virtual town hall June 25.

Safeway and other Albertsons pharmacies will also participate, allowing uninsured clients to fill PrEP prescriptions at no cost.

FDA grants emergency use authorization, but randomized clinical trials of the antiviral drug show mixed results.

Hint: Gilead Sciences donated the meds for Trump’s HIV prevention program, so that cost isn’t the issue.

Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.

Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

Jevon Martin, CEO of Princess Janae Place, addresses the challenges facing trans people—including COVID-19.

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

Gilead Sciences is giving its antiviral remdesivir to nearly 1,000 people as part of two clinical trials.

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.